Prosecution Insights
Last updated: August 17, 2026
Application No. 18/800,228

CONTROLLING AN ULTRASONIC SURGICAL INSTRUMENT ACCORDING TO TISSUE LOCATION

Non-Final OA §112
Filed
Aug 12, 2024
Priority
Dec 28, 2017 — provisional 62/611,340 +16 more
Examiner
COLLINS, SEAN W
Art Unit
3794
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Cilag GmbH International
OA Round
1 (Non-Final)
75%
Grant Probability
Favorable
1-2
OA Rounds
1y 3m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allowance Rate
267 granted / 358 resolved
+4.6% vs TC avg
Strong +27% interview lift
Without
With
+27.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
27 currently pending
Career history
383
Total Applications
across all art units

Statute-Specific Performance

§101
2.0%
-38.0% vs TC avg
§103
46.3%
+6.3% vs TC avg
§102
17.0%
-23.0% vs TC avg
§112
28.9%
-11.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 358 resolved cases

Office Action

§112
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after allowance or after an Office action under Ex Parte Quayle, 25 USPQ 74, 453 O.G. 213 (Comm'r Pat. 1935). Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, prosecution in this application has been reopened pursuant to 37 CFR 1.114. Applicant's submission filed on 07 July 2026 has been entered. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 30-34 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 30 recites the limitation "the ultrasonic generator" in lines 8-9. There is insufficient antecedent basis for this limitation in the claim. Claims 31-34 are rejected by virtue of their dependency upon an indefinite base claim. Allowable Subject Matter Claims 25-29 and 35-39 are allowed. Pursuant to the amendments agreed upon for Examiner’s Amendment on 27 March 2026. Claims 30-34 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action. The following is a statement of reasons for the indication of allowable subject matter: The closest prior art, Yates et al. (US 2016/0058492) and Giordano et al. (US 20100036405), fails to reasonably teach or suggest determine a location of tissue positioned within the end effector according to a difference between the plateau values of the ultrasonic transducer relative to a threshold when considered in combination with the additional requirements of the claims. Yates and Giordano both teach ultrasonic instruments having end effectors having blades, as well as comparison of ultrasonic impedance during varying levels of power to thresholds. However, the prior art of record is silent with regard to comparing ultrasonic impedances to a threshold in order to determine a location of tissue positioned within the end effector. Additionally, despite the recitations of mathematical calculation and the abstract ideas of evaluation and judgement, the examiner contends that the claims are patent eligible because the mathematical concepts and mental processes are integrated into a practical application since they are judicial exceptions applied by use of a particular machine. The claims require an ultrasonic surgical instrument having an ultrasonic blade and an ultrasonic transducer impedance measurement circuit configured to collect measurements in a specific manner, in order to permit the claimed method to be performed, therefore the machine “play(s) a significant part in permitting the claimed method to be performed, rather than function(ing) solely as an obvious mechanism for permitting a solution to be achieved more quickly” and therefore provides significantly more than a judicial exception, See, e.g., Versata Development Group v. SAP America, 793 F.3d 1306, 1335, 115 USPQ2d 1681, 1702 (Fed. Cir. 2015) and MPEP 2106.05(b)(II). Additionally, the judicial exception pertains to an improvement in the technology since the claim reflects a technological solution, using first and second ultrasonic impedance measurements that attain a plateau value, to a technological problem, determining where tissue is positioned when tissue is positioned within the end effector (see Specification [0531]). This is indicative of integration into a practical application of a judicial exception under the “Improvements” consideration, see MPEP 2106.05(a). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SEAN W COLLINS whose telephone number is (408)918-7607. The examiner can normally be reached M-F 9:00 AM-5:00 PM ET. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joanne Rodden can be reached at 303-297-4276. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SEAN W COLLINS/Primary Examiner, Art Unit 3794
Read full office action

Prosecution Timeline

Aug 12, 2024
Application Filed
Mar 27, 2026
Examiner Interview (Telephonic)
Jul 07, 2026
Request for Continued Examination
Jul 16, 2026
Response after Non-Final Action
Jul 23, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12697161
SYSTEMS, METHODS AND APPARATUSES FOR AN ELECTROSURGICAL RF GENERATOR FOR ELECTROSURGICAL CUTTING
3y 2m to grant Granted Aug 04, 2026
Patent 12685581
BIPOLAR NEEDLE WITH ADJUSTABLE ELECTRODE FOR GEOMETRICALLY CONTROLLED THERMAL ABLATION OF BIOLOGICAL TISSUE
3y 7m to grant Granted Jul 21, 2026
Patent 12685583
ELECTROCAUTERY RHIZOTOMY USING WANDING OF ENERGIZED ELECTROCAUTERY PROBE
1y 10m to grant Granted Jul 21, 2026
Patent 12672765
MOTOR SPEED CONTROL CIRCUITS FOR SURGICAL SYSTEMS
2y 0m to grant Granted Jul 07, 2026
Patent 12661177
DEVICES AND METHODS FOR TREATMENT OF HEART FAILURE BY SPLANCHNIC NERVE ABLATION
3y 11m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
75%
Grant Probability
99%
With Interview (+27.1%)
3y 3m (~1y 3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 358 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month